The poultry vaccines industry in Benelux focuses on safeguarding animal health, ensuring safe food production, and enhancing biosecurity measures. Companies in this sector range from biotech firms developing innovative vaccine technologies to established agricultural companies delivering vaccination solutions and support. Recent advancements have brought more effective and safer vaccines to the market. Given the rising demand for sustainable poultry production and the emphasis on animal welfare, the industry is expected to grow as companies innovate and respond to emerging diseases, keeping the farming ecosystem healthy and productive.


The top poultry vaccines investors in Benelux show a mix of corporate giants and venture capital firms, with a focus on innovation in animal health. Hailing from significant cities like Brussels and Ghent, these investors vary in size, with most being small to medium-sized entities founded from the early 1990s to the mid-2010s. In 2024, they collectively completed several notable investment rounds, demonstrating a robust commitment to strengthening agriculture and biotechnology sectors.


Top 11 Poultry Vaccines Investors in Benelux


1. European Innovation Council (EIC)


The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, the EIC offers various funding programs, including the EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale their technologies. In the context of poultry vaccines, the EIC has been involved in significant transactions such as funding Ovagen, which raised over $8 million in a venture round and received additional grant funding. Similarly, Aviwell, another company in the poultry sector, has received multiple grants from the EIC, including over $2.6 million in 2022 and further undisclosed amounts in 2023. These investments highlight EIC's active role in supporting innovation within the poultry vaccines industry, making it a notable player in this field.


2. V-Bio Ventures

  • Website: v-bio.ventures
  • Type: Venture Capital
  • Headquarters: Ghent, Flanders, Belgium
  • Founded year: 2015
  • Headcount: 1-10
  • Number of deals in 2024: 6
  • LinkedIn: v-bio-ventures

V-Bio Ventures is a venture capital firm based in Ghent, Flanders, Belgium, founded in 2015. The firm specializes in life sciences investments, focusing on supporting innovative companies in therapeutics, diagnostics, and sustainable agriculture. V-Bio Ventures aims to transform scientific innovations into impactful products that address unmet needs in healthcare and agriculture. Notably, they have invested in Animab, a company developing monoclonal antibodies for livestock health, which, while initially focused on piglets, demonstrates their commitment to animal health. Additionally, their investment in AstriVax, which is developing vaccines, showcases their involvement in the vaccine sector, although not specifically in poultry. Their portfolio also includes companies like Protealis, which focuses on sustainable plant proteins, indicating a broader interest in agricultural innovations.


3. Anterra Capital

  • Website: anterracapital.com
  • Type: Venture Capital
  • Headquarters: Amsterdam, North Holland, Netherlands
  • Founded year: 2013
  • Headcount: 11-50
  • Number of deals in 2024: 9
  • LinkedIn: anterra-capital

Anterra Capital is a venture capital firm based in Amsterdam, Netherlands, specializing in agrifood technology investments. Founded in 2013, the firm focuses on supporting startups that leverage biotechnology and digital solutions to enhance food production and sustainability. Anterra Capital operates primarily in North America and Europe, targeting innovative companies in the agrifood sector. Notable transactions include their participation in the Series A funding round for Ashish Life Science, an Indian animal health startup, which raised $6.3 million to scale its business and expand into regulated markets, including Europe. This investment highlights Anterra's commitment to the animal health sector, which is relevant to poultry vaccines. Additionally, they have been involved in funding rounds for companies like Animol Discovery, which operates in the animal health space, further indicating their interest in sectors that could intersect with poultry health and vaccines.


4. Pmv

  • Website: pmv.eu
  • Type: Venture Capital
  • Headquarters: Brussels, Brussels, Belgium
  • Founded year: 2001
  • Headcount: 51-200
  • Number of deals in 2024: 11
  • LinkedIn: pmv-eu

Participatiemaatschappij Vlaanderen (PMV) is a public investment company based in Brussels, Belgium, founded in 2001. It acts as a venture capital firm providing a range of financing solutions, including loans and co-financing, to startups, scale-ups, and established businesses across various sectors such as real estate, clean tech, and life sciences. PMV also offers consulting services to help businesses navigate investment challenges and achieve sustainable growth. Notably, PMV has participated in several transactions relevant to the veterinary and livestock health sectors, including ViroVet, which focuses on veterinary products, and Animab, which develops monoclonal antibodies for livestock health. These investments highlight PMV's engagement in the animal health market, which is pertinent to poultry vaccines.


5. Vib

  • Website: vib.be
  • Type: Corporate
  • Headquarters: Ghent, Flanders, Belgium
  • Founded year: 1995
  • Headcount: 1001-5000
  • Number of deals in 2024: 3
  • LinkedIn: vib

VIB (Vlaams Instituut voor Biotechnologie) is a public entity based in Ghent, Flanders, Belgium, founded in 1995. It specializes in strategic research in life sciences and biotechnology, providing research and development services, technology transfer, and support for biotech startups. VIB collaborates with academic institutions and industry partners to translate scientific discoveries into practical applications, addressing the needs of researchers and organizations in the life sciences sector. Notably, VIB has been involved in several transactions relevant to animal health, including investments in Animab, which focuses on developing monoclonal antibodies for livestock health, and Biotalys, which is engaged in agricultural biotechnology. These activities highlight VIB's commitment to improving animal health, which is closely related to the poultry vaccines industry.


6. Agri Investment Fund

  • Website: aifund.be
  • Type: Private Equity
  • Headquarters: Leuven, Flanders, Belgium
  • Founded year: 1890
  • Headcount: 1-10
  • Number of deals in 2024: 3
  • LinkedIn:

Agri Investment Fund is a private equity firm based in Leuven, Flanders, Belgium, founded in 1890. The fund specializes in the agricultural sector, particularly in Ag-Tech and Agro-Food companies, providing financial support and advisory services to both startups and established businesses. Their mission is to foster innovation and sustainability in agriculture. Notably, Agri Investment Fund participated in the Series B financing round for ViroVet, a Belgian biopharmaceutical company focused on veterinary products, which is relevant to the poultry vaccines sector. They also invested in Animab, a company developing monoclonal antibodies for livestock health, indicating their interest in animal health solutions. Additionally, their involvement in Biotalys, which focuses on sustainable agricultural solutions, further emphasizes their commitment to enhancing agricultural practices. Overall, Agri Investment Fund's investment strategy aligns with the goals of improving animal health and sustainability in agriculture, making them a significant player in the sector.


7. Qbic Fund | Venture Capital

  • Website: qbic.be
  • Type: Venture Capital
  • Headquarters: Ghent, Flanders, Belgium
  • Founded year: 2012
  • Headcount: 1-10
  • Number of deals in 2024: 5
  • LinkedIn: qbic

Qbic Fund | Venture Capital is a venture capital fund based in Ghent, Flanders, Belgium, founded in 2012. The fund specializes in seed and early-stage investments in innovative companies across various sectors, with a strong emphasis on biotechnology and technology. Qbic aims to create impact by transforming technological breakthroughs into sustainable businesses, supporting its portfolio companies throughout their growth. Notable transactions include investments in Biotalys, which raised over $39 million in Series C funding, and Aphea.Bio, which raised a total of approximately $26 million across multiple funding rounds. Aphea.Bio focuses on developing sustainable agricultural products using natural microorganisms, which aligns with the goals of enhancing agricultural productivity and could relate to poultry health and vaccines.


8. Capricorn Partners


Capricorn Partners is an investment management firm based in Leuven, Flanders, Belgium, specializing in venture capital, growth capital, and quoted equity funds. Founded in 1993, the firm focuses on innovative companies across sectors such as digital technologies, health, and clean technologies. They are committed to responsible investing, aiming to create both financial returns and strategic value for their clients. Notably, Capricorn Partners has participated in funding rounds for ViroVet, a Belgian biopharmaceutical company that develops veterinary products, including those relevant to poultry. Their involvement in ViroVet's Series A and Series B financing rounds highlights their interest in the veterinary sector, which is pertinent to poultry vaccines. Additionally, they have engaged in other biotechnology investments, indicating a broader interest in health-related innovations.


9. Rabo Private Equity


Rabo Private Equity, founded in 2002 and based in Amsterdam, is a private equity firm that specializes in providing equity capital and investment management services primarily to established and transformative companies in the Food & Agri and Sustainability sectors. The firm leverages its global network and partners with top-tier funds to support its clients' growth and transition efforts. In 2024, Rabo Private Equity participated in several notable transactions, including a $26.5 million Series A investment in Arkea Bio, which focuses on agricultural biotechnology. They also participated in funding rounds for ViAqua Therapeutics, which is involved in innovative solutions for animal health, and Trace Genomics, which focuses on agricultural technology. These transactions highlight Rabo's commitment to advancing agricultural innovations, which may include applications relevant to poultry vaccines.


10. Hendrix Genetics


Hendrix Genetics is a corporate investor based in Boxmeer, North Brabant, Netherlands, specializing in animal breeding solutions across various species, including poultry, swine, and fish. Founded in 1991, the company has established itself as a leader in providing high-quality breeding programs aimed at improving productivity for farmers and producers globally. Hendrix Genetics has made notable acquisitions in the poultry sector, such as the purchase of Joice and Hill Poultry Ltd. in 2010, which was integrated into its poultry distribution division. This acquisition, along with their previous stake in the company, underscores their commitment to the poultry industry. Additionally, their acquisition of Euribrid in 2007 further demonstrates their focus on enhancing breeding capabilities, which is essential for the overall health and productivity of poultry, thereby linking them to the poultry vaccines market indirectly. The company operates with a focus on sustainable practices, aligning with the growing demand for responsible animal protein production.


11. TCD Capital (ex TheClubDeal)

  • Website: tcd-capital.com
  • Type: Corporate
  • Headquarters: Saint-Gilles, Brussels, Belgium
  • Founded year: 2016
  • Headcount: 1-10
  • Number of deals in 2024: 2
  • LinkedIn: theclubdeal-sa

TCD Capital (ex TheClubDeal) is an investment management company based in Saint-Gilles, Brussels, Belgium, founded in 2016. The firm specializes in venture capital, focusing on providing funding and strategic support to Scale-Ups in various sectors, including Smart Living, Technology, and Life Sciences. TCD Capital partners with local entrepreneurs to enhance governance and drive growth, ensuring that its portfolio companies can effectively scale their operations. Notably, TCD Capital has been involved in significant transactions within the life sciences sector, including investments in Univercells, a company dedicated to vaccine development and biomanufacturing. Their recent funding rounds for Univercells, including a €44 million Series D round and previous Series C and B rounds, highlight their commitment to supporting vaccine-related initiatives, which aligns with the poultry vaccines industry.



Poultry Vaccines Insights: Key Investors in Benelux


InvestorHeadquarterSizeFoundedDeals 2024
European Innovation Council (EIC)Brussels, Brussels, Belgium201-500195857
V-Bio VenturesGhent, Flanders, Belgium1-1020156
Anterra CapitalAmsterdam, North Holland, Netherlands11-5020139
PmvBrussels, Brussels, Belgium51-200200111
VibGhent, Flanders, Belgium1001-500019953
Agri Investment FundLeuven, Flanders, Belgium1-1018903
Qbic Fund | Venture CapitalGhent, Flanders, Belgium1-1020125
Capricorn PartnersLeuven, Flanders, Belgium11-5019935
Rabo Private EquityAmsterdam, North Holland, Netherlands11-5020023
Hendrix GeneticsBoxmeer, North Brabant, Netherlands1001-500019910
TCD Capital (ex TheClubDeal)Saint-Gilles, Brussels, Belgium1-1020162


Want to find more investors focusing on the poultry vaccines industry?

If you want to find more investors that are active in the poultry vaccinesindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!